1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Amgen, Inc. (AMGN): Amgen: GSK's Promacta Stealing Nplate's Thunder – Seeking Alpha

October 11, 2013Monoclonal Anti-CD20 Antibodiesadmin

Amgen, Inc. (AMGN): Amgen: GSK's Promacta Stealing Nplate's Thunder
Seeking Alpha
OB) Rituxan (Rituximab). If symptoms persist, surgical removal of the spleen, splenectomy, might be required. Amgen's Nplate (romiplostim) and GlaxoSmithKline's (GSK) Promacta (Eltrombopag) are two recently approved medications from a new class of ...

and more »

Post navigation

← Hair in High Demand – Huffington Post UK Geographic location may help explain why Hispanics face disparities in kidney … – NephrologyNews.com →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos